SE501548C2 - Isokinolinderivat, deras framställning och deras användning - Google Patents

Isokinolinderivat, deras framställning och deras användning

Info

Publication number
SE501548C2
SE501548C2 SE8900039A SE8900039A SE501548C2 SE 501548 C2 SE501548 C2 SE 501548C2 SE 8900039 A SE8900039 A SE 8900039A SE 8900039 A SE8900039 A SE 8900039A SE 501548 C2 SE501548 C2 SE 501548C2
Authority
SE
Sweden
Prior art keywords
dimethoxy
formula
hydrogen
dimethoxyphenyl
compound
Prior art date
Application number
SE8900039A
Other languages
English (en)
Swedish (sv)
Other versions
SE8900039L (sv
SE8900039D0 (sv
Inventor
Klaus Hasspacher
Reto Naef
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8900039D0 publication Critical patent/SE8900039D0/xx
Publication of SE8900039L publication Critical patent/SE8900039L/xx
Publication of SE501548C2 publication Critical patent/SE501548C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8900039A 1988-01-08 1989-01-05 Isokinolinderivat, deras framställning och deras användning SE501548C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888800397A GB8800397D0 (en) 1988-01-08 1988-01-08 Improvements in/relating to organic compounds

Publications (3)

Publication Number Publication Date
SE8900039D0 SE8900039D0 (sv) 1989-01-05
SE8900039L SE8900039L (sv) 1989-07-09
SE501548C2 true SE501548C2 (sv) 1995-03-13

Family

ID=10629678

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8900039A SE501548C2 (sv) 1988-01-08 1989-01-05 Isokinolinderivat, deras framställning och deras användning

Country Status (28)

Country Link
US (1) US4980359A (de)
JP (1) JPH0649686B2 (de)
KR (1) KR0142686B1 (de)
AT (1) AT394365B (de)
AU (1) AU622429B2 (de)
BE (1) BE1002730A3 (de)
CA (1) CA1332944C (de)
CH (1) CH678727A5 (de)
DE (1) DE3900233C2 (de)
DK (1) DK5789A (de)
ES (1) ES2010071A6 (de)
FI (1) FI90865C (de)
FR (1) FR2625743B1 (de)
GB (2) GB8800397D0 (de)
GR (1) GR1002750B (de)
HU (1) HU205083B (de)
IE (1) IE61914B1 (de)
IL (1) IL88899A (de)
IT (1) IT1229523B (de)
LU (1) LU87423A1 (de)
MY (1) MY103963A (de)
NL (1) NL8900029A (de)
NZ (1) NZ227561A (de)
PH (1) PH25640A (de)
PL (1) PL156099B1 (de)
PT (1) PT89405B (de)
SE (1) SE501548C2 (de)
ZA (1) ZA89133B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2723674A (en) * 1951-11-28 1955-11-15 Charles E Harris Telephone cableman's tent
US3007541A (en) * 1959-02-24 1961-11-07 Jr John B Mast Temporary covering and support structure therefor
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof
US4956371A (en) * 1989-09-19 1990-09-11 Euroceltique, S.A. Substituted isoquinolines and methods of using same
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
KR930703259A (ko) * 1990-12-17 1993-11-29 알베르투스 빌헬무스 요아네스 쩨스트라텐 살균성 이소퀴놀린 유도체
CA2093577C (en) * 1992-05-07 2006-01-03 Michael Klaus Alkyl or alkoxy substituted s-heterocyclic retinoids
US5350423A (en) * 1992-09-23 1994-09-27 Burlington Industries Inc. Fabric finishing procedure
GB9322828D0 (en) * 1993-11-05 1993-12-22 Sandoz Ltd Organic compounds
US5783184A (en) * 1994-12-23 1998-07-21 Smithkline Beecham Corporation Method for treatment and diagnosis of IL-5 mediated disorders
JP2001523083A (ja) * 1994-12-23 2001-11-20 スミスクライン・ビーチャム・コーポレイション Ｉｌ−５により媒介される疾病の治療に有用な組み換えｉｌ−５アンタゴニスト
US7399837B2 (en) * 1995-12-22 2008-07-15 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US5693323A (en) * 1994-12-23 1997-12-02 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
GB9622386D0 (en) * 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
IT1296985B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
JP2002534506A (ja) 1999-01-15 2002-10-15 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング Ｐｄｅ−ｉｖ抑制作用を有する多重に置換された６−フェニルフェナントリジン
SI1212089T1 (sl) 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
WO2008134724A2 (en) * 2007-04-30 2008-11-06 Smithkline Beecham Corporation Methods for administering anti-il-5 antibodies
EP2274009B1 (de) 2008-03-28 2013-11-13 GlaxoSmithKline LLC Behandlungsverfahren
EP2337788B1 (de) 2008-10-17 2016-03-23 Wisconsin Alumni Research Foundation Verfahren zur herstellung biologisch aktiver alpha-beta-peptide
JP7295038B2 (ja) 2017-06-06 2023-06-20 グラクソスミスクライン エルエルシー 小児患者のための生物薬剤組成物及び方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB645139A (en) * 1946-10-22 1950-10-25 Servita Gyogyszeryar Es Vegyip Improved process for the production of isoquinoline derivatives
DE1184344B (de) * 1962-06-16 1964-12-31 Orgamol Sa Verfahren zur Herstellung von Isochinolinderivaten
US3878215A (en) * 1971-12-01 1975-04-15 Sandoz Ag 2-Alkyl-3-substituted-4-aryl isoquinolines
DE2401453A1 (de) * 1973-01-16 1974-07-18 John James Voorhees Pharmazeutische zusammensetzung zur behandlung von hautproliferationserkrankungen
US4018927A (en) * 1973-12-17 1977-04-19 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with papaverine alkaloids
DE2503156A1 (de) * 1974-02-05 1975-08-07 Sandoz Ag Verfahren zur herstellung neuer heterocyclischer verbindungen
DE2811361A1 (de) * 1978-03-16 1979-09-27 Hoechst Ag Neue isochinolinaldehyde und verfahren zu ihrer herstellung
DE3244594A1 (de) * 1982-12-02 1984-06-07 Hoechst Ag, 6230 Frankfurt 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung
HU196758B (en) * 1986-05-21 1989-01-30 Gyogyszerkutato Intezet Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them
CA1330560C (en) * 1986-05-21 1994-07-05 Maurits E. A. Vandewalle Di- and tetrahydroisoquinoline derivatives

Also Published As

Publication number Publication date
IL88899A (en) 1994-07-31
PL277092A1 (en) 1989-09-04
ZA89133B (en) 1990-09-26
PT89405A (pt) 1990-02-08
FI890072A0 (fi) 1989-01-06
DK5789D0 (da) 1989-01-06
IT8947504A0 (it) 1989-01-04
GB8900102D0 (en) 1989-03-01
ATA3589A (de) 1991-09-15
AU622429B2 (en) 1992-04-09
SE8900039L (sv) 1989-07-09
FI890072A (fi) 1989-07-09
DK5789A (da) 1989-07-09
FI90865C (fi) 1994-04-11
GB2213482B (en) 1991-09-11
IT1229523B (it) 1991-09-04
CH678727A5 (de) 1991-10-31
HUT52061A (en) 1990-06-28
ES2010071A6 (es) 1989-10-16
KR890011851A (ko) 1989-08-22
AU2779589A (en) 1989-07-20
GB8800397D0 (en) 1988-02-10
IE61914B1 (en) 1994-11-30
IL88899A0 (en) 1989-08-15
PH25640A (en) 1991-08-21
DE3900233A1 (de) 1989-07-20
PT89405B (pt) 1993-09-30
HU205083B (en) 1992-03-30
US4980359A (en) 1990-12-25
IE890037L (en) 1989-07-08
AT394365B (de) 1992-03-25
CA1332944C (en) 1994-11-08
NL8900029A (nl) 1989-08-01
GB2213482A (en) 1989-08-16
GR1002750B (el) 1997-08-26
FI90865B (fi) 1993-12-31
DE3900233C2 (de) 2000-04-27
MY103963A (en) 1993-10-30
JPH0649686B2 (ja) 1994-06-29
KR0142686B1 (ko) 1998-07-15
JPH01213267A (ja) 1989-08-28
NZ227561A (en) 1991-11-26
LU87423A1 (fr) 1989-08-30
PL156099B1 (pl) 1992-02-28
SE8900039D0 (sv) 1989-01-05
FR2625743A1 (fr) 1989-07-13
BE1002730A3 (fr) 1991-05-21
FR2625743B1 (fr) 1990-11-09
GR890100008A (el) 1994-03-31

Similar Documents

Publication Publication Date Title
SE501548C2 (sv) Isokinolinderivat, deras framställning och deras användning
US5177085A (en) Dihydro-isoquinoline derivatives, processes for their production, pharmaceutical compositions containing them, and their use in treating asthma
DK169337B1 (da) Xanthinforbindelser, farmaceutisk præparat indeholdende disse, xanthinforbindelser til anvendelse som et farmaceutisk middel samt fremgangsmåde til fremstilling af forbindelserne
US5905156A (en) Benzopyrans and pharmaceutical compositions containing them
US4791121A (en) 4-phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
US5574049A (en) 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans
WO1994012493A1 (en) 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals
EP0435235A1 (de) Isochinolinderivate und ihre Salze als Proteasehemmer
EP0035819A1 (de) Chinolinderivate, solche Verbindungen enthaltende pharmazeutische Zusammensetzungen und Verfahren zur Herstellung dieser Verbindungen
JPH03294277A (ja) ピペリジン誘導体
JPH02135A (ja) 多還式化合物とこれを含有する医薬組成物
AU665040B2 (en) 4-carboxamido-6(pyridin-4-yl substituted benzopyran derivatives
MXPA97009004A (en) Benzopira
PL154160B1 (pl) Sposób wytwarzania nowych pochodnych ksantyny